CHIH-YUAN LEECHING-YAO YANGWEI-CHOU LINChen Chien ChiaMENG-KUN TSAI2020-09-292020-09-292020-040929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/515712To review the results of renal transplantation after promulgation of the Human Organ Transplant Act in Taiwan in 1987, we conducted a retrospective study in the first 1000 cases performed in our hospital. Prognostic factors for graft survival were assessed with emphasis on the impact of donor-specific antibody (DSA).animationGraft survival; Kidney transplantation; Prognostic factor[SDGs]SDG3alloantibody; antibody; complement component C4d; cyclosporine; donor specific antibody; everolimus; HLA antibody; immunoglobulin; methylprednisolone; mycophenolate mofetil; mycophenolic acid; panel reactive antibody; prednisolone; rapamycin; rituximab; sulfamethoxazole; tacrolimus; trimethoprim; unclassified drug; valganciclovir; HLA antigen; adult; antibody detection; antibody mediated rejection; Article; cohort analysis; delayed graft function; desensitization; double filtration plasmapheresis; drug bioavailability; female; glomerulonephritis; graft failure; graft renal biopsy; graft survival; HLA system; human; human tissue; immunosuppressive treatment; infection prevention; kidney biopsy; kidney disease; kidney graft; major clinical study; male; plasmapheresis; Pneumocystis pneumonia; prognosis; recurrent disease; retrospective study; risk factor; sex ratio; Taiwan; transplantation conditioning; blood group ABO system; graft rejection; immunology; kidney transplantation; living donor; middle aged; mortality; prognosis; survival analysis; survival rate; ABO Blood-Group System; Adult; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Kidney Transplantation; Living Donors; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Survival Rate; Taiwanjournal article10.1016/j.jfma.2019.11.00831818714WOS:000523557600008